The decision between surgical and non-surgical options isnt always straightforward
Mechanism of Action: Wegovy shares its mechanism of action with Ozempic and Semaglutide, acting as a GLP-1 receptor agonist, reducing appetite and promoting satiety
The EU market remains limited for such products due to strict health claims rules
served as a consultant or on an advisory board for 35Pharma, Alnylam, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Dexcom, Eli Lilly, Esperion Therapeutics, Janssen, Lexicon Pharmaceuticals, Merck (Diabetes and Cardiovascular), Novo Nordisk, Pharmacosmos, Pfizer, scPharmaceuticals, Sanofi, Structure Therapeutics, Vifor and Youngene Therapeutics
This review synthesizes peer-reviewed evidence from 20202026, prioritizing systematic reviews, meta-analyses, and clinical trials